Results 221 to 230 of about 26,042 (243)

Imatinib Mesylate

2011
openaire   +2 more sources

Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia

Nature Reviews Cancer, 2007
Andreas Hochhaus
exaly  

Imatinib Mesylate

2017
openaire   +1 more source

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate

Nature Medicine, 2006
Risto Kerkelä, Anthony Rosenzweig, Richard A Van Etten   +2 more
exaly  

Imatinib Mesylate

2006
openaire   +1 more source

Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications

Nature Medicine, 2006
Ingo Roeder, Ingmar Glauche, Andreas Hochhaus   +2 more
exaly  

Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor

Science, 2004
Charles L Sawyers
exaly  

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

Lancet, The, 2006
George D Demetri, Jaap Verweij, Grant Mcarthur   +2 more
exaly  

Imatinib and beyond—exploring the full potential of targeted therapy for CML

Nature Reviews Clinical Oncology, 2009
Hagop M Kantarjian, Jorge Cortes
exaly  

Activation of p53 by SIRT1 Inhibition Enhances Elimination of CML Leukemia Stem Cells in Combination with Imatinib

Cancer Cell, 2012
Ling Li, Zhiqiang Wang, Tessa L Holyoake
exaly